Altimmune, Angion Biomedica down double digits after reporting disappointing trial data Check out this evening's top movers from around Wall Street, compiled by The Fly.
UP AFTER EARNINGS
ALSO HIGHER
- VOXX International (VOXX) up 5.8% after being initiated with Buy at DA Davidson
- Cyteir Therapeutics (CYTE) up 5.7% after disclosing passive stake from RA Capital
DOWN AFTER EARNINGS
- Qumu (QUMU) down 19.5% after reporting preliminary Q2 revenue
- AeroVironment (AVAV) down 4.4%
ALSO LOWER
- Altimmune (ALT) down 36.4% after announcing it will discontinue further development of AdCOVID vaccine due to inferior immune response
- Angion Biomedica (ANGN) down 10.4% after announcing its ALI-201 trial did not meet primary, secondary endpoints
- Riley Exploration (REPX) down 9.9% after equity offering
- Grid Dynamics (GDYN) down 8.3% after equity offering
- Cerevel Therapeutics (CERE) down 6.1% after equity offering
- MongoDB (MDB) down 4.2% after equity offering
Symbols:
POWW VOXX CYT QUMU AVAV ALT ANGN REPX GDYN CERE MDB - $383.51 /
-5.495 (-1.41%)
Keywords: fly intel, wall street, afterhours, movers, top stories, stocks